Amended loan schedule details $9.59M in debt facilities.
Acura Pharmaceuticals updated its borrowing agreements, recognizing $9.594M in additional loans and extending notes through 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day